Codexis

Codexis Liabilities

The The Liabilities of Codexis (CDXS) as of Sep 26, 2026 is 97.27 M USD. In the previous year, The Liabilities was 82.08 M USD — a change of 18.50% (higher).

Liabilities

97.27 MUSD

YoY

18.50%

Last updated:

In 2026, Codexis's total liabilities amounted to 97.27 M USD, a 18.50% difference from the 82.08 M USD total liabilities in the previous year.

The Codexis Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
21.98 M USD
Jan 1, 2019
43.56 M USD
Jan 1, 2020
51.54 M USD
Jan 1, 2021
81.99 M USD
Jan 1, 2022
105.60 M USD
Jan 1, 2023
49.95 M USD
Jan 1, 2024
82.08 M USD
Jan 1, 2025
97.27 M USD
The Codexis Liabilities history
YEARLiabilitiesYoY
97.27 MUSD+18.50%
82.08 MUSD+64.35%
49.95 MUSD-52.70%
105.60 MUSD+28.79%
81.99 MUSD+59.07%
51.54 MUSD+18.34%
43.56 MUSD+98.19%
21.98 MUSD-24.42%
29.08 MUSD+75.71%
16.55 MUSD-23.98%
21.77 MUSD-0.20%
21.81 MUSD—
Access this data via the Eulerpool API

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Codexis's Liabilities

Codexis's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Codexis's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Codexis's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Codexis's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Codexis’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Codexis stock

The Liabilities of Codexis is 97.27 M USD in 2026.

The Liabilities of Codexis changed from 82.08 M USD to 97.27 M USD, representing a 18.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Codexis since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Codexis historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Codexis

All Key Metrics — Codexis